|
Research In Motion Ltd., up 89 cents at $17.37 A Bernstein analyst upgraded shares of the BlackBerry maker saying that even though the company is in decline, it still has value. Onyx Pharmaceuticals Inc., up $1.88 at $44.68 The biopharmaceutical said that the FDA accepted its marketing application for carfilzomib, a potential blood cancer treatment. Inhibitex Inc., up $2.30 at $13.70 The biopharmaceutical company said it will ask the FDA for authorization to expand studies of its experimental hepatitis C drug.
Copyright 2011 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor